Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Real-time Estimate Tradegate  -  09:35:58 2023-03-22 am EDT
56.94 EUR   -0.43%
03:15aSyngenta 4Q profit falls as raw material prices increase
RE
03:04aSyngenta 4Q profit falls as raw material prices increase
RE
03/20Swiss Banking Rescue Deal, Cooling PPI Push German Shares Higher
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BAYER AG
03/14Bayer : BlueRock Therapeutics to incorporate wearable and invisible contactless digital he..
PU
03/13BAYER AG : Buy rating from Jefferies
MD
03/09Germany's Bayer Lines Up $1 Billion US Pharma R&D Investment in FY23
MT
03/09Bayer plans to spend $1 billion on US pharma R&D in 2023-US pharma head
RE
03/08Bayer Unveils the Preceon™ Smart Corn System, Transforming How Farmers Manage Thei..
CI
03/07BAYER AG : Credit Suisse reaffirms its Neutral rating
MD
03/07Bayer Joins Pilot Project to Reduce, Replace Animal Testing in Consumer Health Industry
MT
03/06Stada benefits from wave of illnesses and strong Russian business
DP
03/01Bernstein rates Bayer 'Outperform' - Target 94 euros
DP
03/01BAYER AG : DZ Bank reaffirms its Buy rating
MD
03/01BAYER AG : Bernstein reaffirms its Buy rating
MD
03/01Bayer Receives Marketing Authorization in EU for Additional Indication of Prostate Canc..
MT
03/01Bayer : Nubeqa™ (darolutamide) receives EU approval for additional indication in pro..
PU
03/01Bayer: Nubeqa approved in the EU against further prostate cancer
DP
03/01Bayer : submits aflibercept 8 mg for marketing authorization in Japan
PU
More most relevant news
All news about BAYER AG
03:15aSyngenta 4Q profit falls as raw material prices increase
RE
03:04aSyngenta 4Q profit falls as raw material prices increase
RE
03/20Swiss Banking Rescue Deal, Cooling PPI Push German Shares Higher
MT
03/20Orion, Bayer's Prostrate Cancer Treatment Darolutamide Wins Chinese Regulatory Nod
MT
03/14Bayer : BlueRock Therapeutics to incorporate wearable and invisible contactless digital he..
PU
03/13BAYER AG : Buy rating from Jefferies
MD
03/09Germany's Bayer Lines Up $1 Billion US Pharma R&D Investment in FY23
MT
03/09Bayer plans to spend $1 billion on US pharma R&D in 2023-US pharma head
RE
03/09European Midday Briefing: Fed Rate Path Worries Continue to Wei..
DJ
03/09EMEA Morning Briefing: Stocks Seen Lower as Powell Comments, Earni..
DJ
More news
News in other languages on BAYER AG
06:44aSyngenta: vendite record nel 2022 grazie ad elevati prezzi agricoli
03:15aLe bénéfice de Syngenta au quatrième trimestre diminue en raison de la hausse des prix ..
01:05aWOCHENVORSCHAU: Termine bis 4. April 2023
03/21Bayer : nouvelle indication en Chine pour Nubeqa
03/21Bayer : will mit neuer Wasserstrategie zur Bewältigung der globalen Wasserkrise beitragen
03/20MIDDAY BRIEFING - Unternehmen und Märkte
03/20L'accord sur le sauvetage des banques suisses et le ralentissement de l'IPP poussent le..
03/20Bayer : nouvelle approbation pour Nubeqa en Chine
03/20Le Darolutamide, traitement du cancer de la prostate d'Orion et de Bayer, obtient le fe..
03/20Bayer bekommt erweiterte Zulassung für Krebsmittel Nubeqa in China
More news
Analyst Recommendations on BAYER AG
03/13BAYER AG : Buy rating from Jefferies
MD
03/07BAYER AG : Credit Suisse reaffirms its Neutral rating
MD
03/01Bernstein rates Bayer 'Outperform' - Target 94 euros
DP
03/01BAYER AG : DZ Bank reaffirms its Buy rating
MD
03/01BAYER AG : Bernstein reaffirms its Buy rating
MD
More recommendations
Press releases
03/14Bayer : BlueRock Therapeutics to incorporate wearable and invisible contactless digital he..
PU
03/01Bayer : Nubeqa™ (darolutamide) receives EU approval for additional indication in pro..
PU
03/01Bayer : submits aflibercept 8 mg for marketing authorization in Japan
PU
02/28AskBio Receives European Commission Orphan Drug Designation through its EU-Based subsid..
AQ
02/28Bayer : Address by Board of Management
PU
More press releases
Analysis
Bayer plans to spend $1 billion on US pharma R&D in 2023-US pharma head
Upcoming event on BAYER AG
04/28/23Annual General Meeting
Upcoming sector events
04/18/23JOHNSON & JOHNSON : Q1 2023 Earnings Release
04/27/23ABBVIE INC. : Q1 2023 Earnings Release (Projected)
04/27/23ELI LILLY AND COMPANY : Q1 2023 Earnings Release
04/27/23MERCK & CO., INC. : Q1 2023 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer